Auranofin induces urothelial carcinoma cell death via reactive oxygen species production and synergy with cisplatin

Chia Nan University of Pharmacy & Science Institutional Repository > 環境永續暨休閒學院 > 運動管理系 > 期刊論文 > Item 310902800/34669

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34669

標題:	Auranofin induces urothelial carcinoma cell death via reactive oxygen species production and synergy with cisplatin
作者:	Chen, San-Yuan Chao, Chun-Nun Huang, Hsin-Yi Fang, Chiung-Yao
貢獻者:	Chia-Yi Christian Hospital Department of Sports Management, Chia Nan University of Pharmacy & Science Chia-Yi Christian Hospital Asia University Taiwan Chia-Yi Christian Hospital
關鍵字:	bladder-cancer molecular-mechanisms anticancer activity ros apoptosis checkpoint generation resistance induction stress
日期:	2022
上傳時間:	2023-12-11 14:04:06 (UTC+8)
出版者:	SPANDIDOS PUBL LTD
摘要:	Urothelial carcinoma (UC) is one of the most common cancer types of the urinary tract. UC is associated with poor 5-year survival rate, and resistance to cisplatin-based therapy remains a challenge for invasive bladder cancer treatment. Therefore, there is an urgent need to develop new drugs for advanced UC therapy. Auranofin (AF) was developed over 30 years ago for the treatment of rheumatoid arthritis and has been reported to exert an antitumor effect by increasing the level of reactive oxygen species (ROS) in cancer cells. The aim of the present study was to examine the effects of AF on cancer cell proliferation, cell cycle and apoptosis, either alone or in combination with cisplatin. AF induced cell death in two separate cell lines, HT 1376 and BFTC 909, in a concentration- and time-dependent manner by inducing cell cycle arrest. However, the distribution of cells in different phases of the cell cycle differed between the two cell lines, with G(0)/G(1) cell cycle arrest in HT 1376 cells and S phase arrest in BFTC 909 cells. In addition, AF induced apoptosis in HT 1376, as well as redox imbalance in both HT 1376 and BFTC 909 cells. Cell viability was rescued following treatment with N-acetyl-L-cysteine, a ROS scavenger. Furthermore, AF treatment synergistically increased the cytotoxicity of HT 1376 and BFTC 909 cells when combined with cisplatin treatment. These findings suggest that AF may represent a potential candidate drug against UC and increase the therapeutic effect of cisplatin.
關聯:	ONCOLOGY LETTERS, v.23, n.2, pp.61
显示于类别:	[運動管理系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	281	检视/开启
ol-23-02-13179.pdf		4322Kb	Adobe PDF	108	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....